Marcia F. T. Rupnow, PhD
Advertisement
Articles by Marcia F. T. Rupnow, PhD
Advertisement
Latest Updated Articles
- Participating Faculty: Cost Efficiency of Canagliflozin Versus Sitagliptin for Type 2 Diabetes Mellitus
Published: October 26th 2014 | Updated:
- Cost Efficiency of Canagliflozin Versus Sitagliptin for Type 2 Diabetes Mellitus
Published: October 26th 2014 | Updated:
- Diabetes-Related Quality Measure Attainment: Canagliflozin Versus Sitagliptin Based on a Pooled Analysis of 2 Clinical Trials
Published: December 16th 2014 | Updated:
- Attainment of Diabetes-Related Quality Measures With Canagliflozin Versus Sitagliptin
Published: January 25th 2014 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
2
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
3
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5
